Lorena González

471 total citations
33 papers, 298 citations indexed

About

Lorena González is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Lorena González has authored 33 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Lorena González's work include Diabetes Management and Research (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Diabetes Management and Education (8 papers). Lorena González is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Diabetes Management and Education (8 papers). Lorena González collaborates with scholars based in Argentina, Puerto Rico and United States. Lorena González's co-authors include Juan José Gagliardino, Jorge F. Elgart, Enzo Rucci, Charles M. Clark, Joaquín Caporale, Daniel Assad, Erick Suárez, Ana P. Ortíz, Priscilla Magno and Claudio González and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetic Medicine.

In The Last Decade

Lorena González

30 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorena González Argentina 10 195 96 56 55 23 33 298
Jorge F. Elgart Argentina 12 225 1.2× 72 0.8× 49 0.9× 37 0.7× 32 1.4× 47 323
Shahin Yarahmadi Iran 12 162 0.8× 117 1.2× 25 0.4× 30 0.5× 20 0.9× 25 332
P. K. Hopkinson United Kingdom 4 176 0.9× 67 0.7× 33 0.6× 34 0.6× 55 2.4× 6 276
Naresh Kanumilli United Kingdom 9 227 1.2× 44 0.5× 94 1.7× 40 0.7× 11 0.5× 19 323
Wiam Boutayeb Morocco 10 129 0.7× 75 0.8× 31 0.6× 28 0.5× 25 1.1× 17 276
Pedro Ramos Brazil 10 98 0.5× 32 0.3× 32 0.6× 70 1.3× 56 2.4× 20 265
Mazapuspavina Md Yasin Malaysia 8 79 0.4× 57 0.6× 27 0.5× 32 0.6× 8 0.3× 28 297
Pavithra Vijayakumar United States 8 158 0.8× 37 0.4× 29 0.5× 39 0.7× 47 2.0× 17 350
Irina Lendel United States 6 148 0.8× 116 1.2× 29 0.5× 85 1.5× 14 0.6× 8 258
Lucía Hernández Mexico 4 75 0.4× 40 0.4× 32 0.6× 55 1.0× 7 0.3× 6 230

Countries citing papers authored by Lorena González

Since Specialization
Citations

This map shows the geographic impact of Lorena González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena González more than expected).

Fields of papers citing papers by Lorena González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena González. The network helps show where Lorena González may publish in the future.

Co-authorship network of co-authors of Lorena González

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena González. A scholar is included among the top collaborators of Lorena González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena González. Lorena González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amoruso, Lucía, Hernán Hernandez, Hernando Santamaría‐García, et al.. (2025). Multilingualism protects against accelerated aging in cross-sectional and longitudinal analyses of 27 European countries. Nature Aging. 5(11). 2340–2354. 1 indexed citations
2.
Elgart, Jorge F., et al.. (2018). Ingesta alimentaria en la población adulta de dos ciudades de la Provincia de Buenos Aires: su adecuación a las recomendaciones nutricionales. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 1 indexed citations
3.
Ortíz, Ana P., Guillermo Tortolero‐Luna, Josefina Romaguera, et al.. (2018). Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16–64 years in Puerto Rico. Papillomavirus Research. 5. 109–113. 11 indexed citations
4.
Elgart, Jorge F., et al.. (2017). Improving diabetes care at primary care level with a multistrategic approach: results of the DIAPREM programme. Acta Diabetologica. 54(9). 853–861. 11 indexed citations
5.
Elgart, Jorge F., et al.. (2017). Multistrategic approach to improve quality of care of people with diabetes at the primary care level: Study design and baseline data. Primary care diabetes. 11(2). 193–200. 10 indexed citations
6.
Elgart, Jorge F., et al.. (2017). Relation between cost of drug treatment and body mass index in people with type 2 diabetes in Latin America. PLoS ONE. 12(12). e0189755–e0189755. 2 indexed citations
7.
Ortíz, Ana P., Josefina Romaguera, Cynthia M. Pérez, et al.. (2016). Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico. Papillomavirus Research. 2. 89–96. 8 indexed citations
8.
Elgart, Jorge F., et al.. (2016). COST OF TYPE 2 DIABETES TREATMENT IN LATIN AMERICA: EFFECT OF DEGREE OF METABOLIC CONTROL. Value in Health. 19(3). A201–A201. 1 indexed citations
9.
González, Lorena, Jorge F. Elgart, & Juan José Gagliardino. (2015). Education of people with type 2 diabetes through peers with diabetes: is it cost effective?. SHILAP Revista de lepidopterología. 15(11). e6348–e6348. 8 indexed citations
10.
Elgart, Jorge F., et al.. (2014). Dapagliflozin versus sulfonylurea as an add-on therapy to metformin: A cost-effectiveness analysis in Colombia. Value in Health. 17(3). A247–A247. 2 indexed citations
11.
Elgart, Jorge F., et al.. (2014). Dapagliflozin: Cost-effectiveness as an add-on therapy to metformin in the treatment of type 2 diabetes (T2DM) in Argentina and Chile. Value in Health. 17(3). A248–A248. 2 indexed citations
12.
González, Lorena, Joaquín Caporale, Jorge F. Elgart, & Juan José Gagliardino. (2014). The Burden of Diabetes in Argentina. Global Journal of Health Science. 7(3). 124–33. 11 indexed citations
13.
Elgart, Jorge F., et al.. (2014). Saxagliptin/metformin extended-release (XR) for the type 2 diabetes (T2DM) treatment in venezuela: A budget impact analysis. Value in Health. 17(3). A243–A243. 1 indexed citations
14.
15.
Elgart, Jorge F., et al.. (2013). Abatacept For The Treatment Of Patients With Rheumatoid Arthritis In Argentina: A Cost-Effectiveness Analysis. Value in Health. 16(3). A223–A224.
16.
Elgart, Jorge F., et al.. (2013). Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina. Health Economics Review. 3(1). 11–11. 22 indexed citations
17.
González, Lorena, Priscilla Magno, Ana P. Ortíz, et al.. (2012). Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992–2005. Cancer Epidemiology. 37(1). 5–10. 17 indexed citations
18.
Elgart, Jorge F., et al.. (2010). Obesidad en Argentina: epidemiología, morbimortalidad e impacto económico. SHILAP Revista de lepidopterología. 7 indexed citations
19.
González, Lorena, et al.. (2008). La comunicación interpersonal dentro de la dinámica familiar ante el reto de la adopción. SHILAP Revista de lepidopterología. 1 indexed citations
20.
González, Lorena. (2007). Factores de jerarquización de las informaciones ambientales en el diarismo impreso zuliano. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge F. Elgart Breakdown of academic impact, for papers by Shahin Yarahmadi Breakdown of academic impact, for papers by P. K. Hopkinson Breakdown of academic impact, for papers by Naresh Kanumilli Breakdown of academic impact, for papers by Wiam Boutayeb Breakdown of academic impact, for papers by Pedro Ramos Breakdown of academic impact, for papers by Mazapuspavina Md Yasin Breakdown of academic impact, for papers by Pavithra Vijayakumar Breakdown of academic impact, for papers by Irina Lendel Breakdown of academic impact, for papers by Lucía Hernández
Rankless by CCL
2026